Assessment of novel muscarinic acetylcholine receptors in rat cerebral cortex by a tissue segment binding method

Journal of Pharmacological Sciences

Volumn 112, Issue 4, 2010, Pages 444-451

  Lee, Kung Shing ^a,c   Nishimune, Atsushi ^a,b   Yoshiki, Hatsumi ^a   Anisuzzaman, Abu Syed Md ^a   Suzuki, Fumiko ^a,b   Wang, Mao Hsien ^a   Cheng, Juei Tang ^d   Muramatsu, Ikunobu ^a,b  

^a University of Fukui   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Intracellular receptor; Muscarinic acetylcholine receptor; Quinuclidinyl benzilate; Rat cerebral cortex; Tissue segment binding assay

Indexed keywords

ACETYLCHOLINE; ATROPINE; MEMBRANE RECEPTOR; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BRAIN CORTEX; CELLULAR DISTRIBUTION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; INTERNALIZATION; INTRACELLULAR MEMBRANE; MALE; NONHUMAN; RADIORECEPTOR ASSAY; RAT; RECEPTOR AFFINITY;

EID: 77951222087     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10016FP     Document Type: Article

References (26)

1. Messer WS, Stibbe JR, Bohnett M. Involvement of the septohippocampal cholinergic system in representational memory. Brain Res. 1991;564:66-72.
2. Van Koppen CJ, Kaiser B. Regulation of muscarinic acetylcho-line receptor signaling. Pharmacol Ther. 2003;98:197-220.
3. Wess J, Eglen RM, Gautam D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov. 2007;6:721-733.
4. Rossner S, Ueberham U, Yu J, Kirazov L, Shliebs R, Perez-Polo JR, et al. In vivo regulation of amyloid precursor secretion in rat neocortex by cholinergic activity. Eur J Neurosci. 1997;9:2125-2134.
5. Caulfield MP, Birdsall NJM. International union of pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998;50:279-290.
6. Levey AI. Immunological locarization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 1993;52:441-448.
7. Muramatsu I, Tanaka T, Suzuki F, Zhang L, Hiraizumi-Hiraoka Y, Anisuzzaman ASM, et al. Quantifying receptor properties: the tissue segment binding method - a powerful tool for the pharma-come analysis of native receptors. J Pharmacol Sci. 2005;98:331-339.
8. Berstein G., Haga T, Ichiyama A. Effect of the lipid environment on the differential affinity of purified cerebral and atrial muscarinic acetylcholine receptors for pirenzepine. Mol Pharmacol. 1989;36:601-607.
9. Anisuzzaman ASM, Morishima S, Suzuki F, Tanaka T, Muramatsu I. Identification of M1 muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors. Eur J Pharmacol. 2008;599:146-151.
10. Morishima S, Suzuki F, Yoshiki H, Anisuzzaman ASM, Sathi ZS, Tanaka T, et al. Identification of α1L-adrenceptor in rat cerebral cortex and possible relationship between α1L- and α1A-adrenocpetors. Br J Pharmacol. 2008;153:1485-1494.
11. Muramatsu I, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman ASM, Tanaka T, et al. Identification of α1L-adrenoceptor in mice and its abolition by α1A-adrenocpetor gene knockout. Br J Pharmacol. 2008;155:1224-1234.
12. Su TH, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman ASM, Tanaka T, et al. Native profiles of α1A-adrenocpetor phenotypes in rabbit prostate. Br J Pharmacol. 2008;155:906-912.
13. Yamamura HI, Enna SJ, Kuhar MJ, editors. Neurotransmitter receptor binding. 2nd ed. New York: Raven Press; 1985.
14. Bylund DB, Toews ML. Radioligand binding methods: practical guide and tips. Am J Physiol. 1993;265:L421-L429.
15. Hiraizumi-Hiraoka Y, Tanaka T, Yamamoto H, Suzuki F, Muramatsu I. Identification of α-1L adrenoceptor in rabbit ear artery. J Pharmacol Exp Ther. 2004;310:995-1002.
16. Yoshiki H, Nishimune A, Suzuki F, Morishima S, Ikeda T, Sasaki M, et al. Evaluation of β1L-adrenoceptors in rabbit heart by tissue segment binding assay. J Pharmacol Sci. 2009;110:389-396.
17. Sugimoto H, Yamanishi Y, Iimura Y, Kawakami Y. Donepezil hydrochloride (E2020) and other cholinesterase inhibitors. Curr Med Chem. 2000;7:303-339.
18. Galper JB, Dziekan LC, O'Hara DS, Smith TW. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates. J Biol Chem. 1982;257:10344-10356.
19. Anisuzzaman ASM, Morishima S, Suzuki F, Tanaka T, Yoshiki H, Muramatsu I. Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay. J Pharmacol Sci. 2008;106:271-279.
20. Dessy C, Kelly RA, Balligand JL, Feron O. Dynamic mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J. 2000;19:4272-4280.
21. Furchgott RF. The classification on adrenoceptors (adrenergic receptors): an evaluation from the standpoint of receptor theory. In: Blaschko H and Muscholl E, editors. Handbuch der Experimentellen Pharmakologie. New York: Springer; 1972. Vol. 3, p. 283-335.
22. Lind GJ, Cavanagh HD. Nuclear muscarinic acetylcholine receptors in corneal cells from rabbit. Invest Ophthalmol Vis Sci. 1993;34:2943-2952.
23. Boivin B, Lavoie C, Vaniotis G, Baragli A, Villeneuve LR, Ethier N, et al. Functional β-adrenergic receptor signaling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovas Res. 2006;71:69-78.
24. Wright CD, Chen Q, Baye NL, Huang Y, Healy CL, Karinathan S, et al. Nuclear α1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ Res. 2008;103:992-1000.
25. Boivin B, Chevalier D, Villeneuve LR, Rousseau E, Allen SG. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem. 2003;278:29153-29163.
26. Stiles G, Caron MG, Lefkowitz RJ. β-Adrenergic receptors: Biochemical mechanisms of physiological regulation. Physiol Rev. 1984;64:661-743.